US20120136043A1 - Antisense oligonucleotides (odn) against smad7 and uses thereof in medical field - Google Patents

Antisense oligonucleotides (odn) against smad7 and uses thereof in medical field Download PDF

Info

Publication number
US20120136043A1
US20120136043A1 US13/332,134 US201113332134A US2012136043A1 US 20120136043 A1 US20120136043 A1 US 20120136043A1 US 201113332134 A US201113332134 A US 201113332134A US 2012136043 A1 US2012136043 A1 US 2012136043A1
Authority
US
United States
Prior art keywords
smad7
mice
colitis
antisense
antisense oligonucleotide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US13/332,134
Inventor
Giovanni Monteleone
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nogra Pharma Ltd
Original Assignee
Giovanni Monteleone
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to ITRM20030149 priority Critical patent/ITRM20030149A1/en
Priority to ITRM2003A000149 priority
Priority to PCT/IT2004/000117 priority patent/WO2004087920A1/en
Priority to US10/551,643 priority patent/US7700757B2/en
Priority to US11/501,756 priority patent/US20070042985A1/en
Priority to US12/264,058 priority patent/US7807818B2/en
Priority to US12/854,558 priority patent/US8106182B2/en
Application filed by Giovanni Monteleone filed Critical Giovanni Monteleone
Priority to US13/332,134 priority patent/US20120136043A1/en
Publication of US20120136043A1 publication Critical patent/US20120136043A1/en
Assigned to NOGRA PHARMA LIMITED reassignment NOGRA PHARMA LIMITED CHANGE OF NAME (SEE DOCUMENT FOR DETAILS). Assignors: GIULIANI INTERNATIONAL LIMITED
Application status is Abandoned legal-status Critical

Links